Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.
We have previously shown that the doxorubicin-selected multidrug-resistant small-cell lung-cancer cell line H69AR is resistant to VP-16-induced single-strand DNA breaks as compared with its parental H69 cell line. Levels of immunoreactive topoisomerase II alpha are also reduced in H69AR cells. In the present study, we found that cleaved complex formation in the presence of VP-16 was decreased in H69AR cells as compared with H69 cells. In addition, the resistant cells contained lower levels of both topoisomerase II alpha and topoisomerase II beta protein and mRNA. However, these changes were not accompanied by a decrease in the P4-unknotting (strand-passing) activity of 0.67 M NaCl nuclear extracts of H69AR cells, nor was there any difference in VP-16 inhibition of unknotting activity in the H69 and H69AR nuclear extracts. These data suggest that reduced levels of topoisomerase II alpha and II beta may contribute to the resistance of H69AR cells to VP-16 and other drugs that target these isoenzymes.
Evans
C D
CD
Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada.
Mirski
S E
SE
Danks
M K
MK
Cole
S P
SP
D015152:Blotting, Northern; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000201:enzymology*; D015342:DNA Probes; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D004351:Drug Resistance; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D014407:Tumor Cells, Cultured
D015342:DNA Probes; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D005047:Etoposide; D004250:DNA Topoisomerases, Type II